|
USP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.5812247025151E-14 |
| Normal-vs-Stage2 |
1.21819999998607E-06 |
| Normal-vs-Stage3 |
1.77635683940025E-15 |
| Normal-vs-Stage4 |
2.12252437847837E-12 |
| Stage1-vs-Stage2 |
6.200600E-01 |
| Stage1-vs-Stage3 |
3.352200E-02 |
| Stage1-vs-Stage4 |
2.874100E-02 |
| Stage2-vs-Stage3 |
6.503600E-02 |
| Stage2-vs-Stage4 |
4.592200E-02 |
| Stage3-vs-Stage4 |
5.709800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.69649999995458E-06 |
| Normal-vs-Asian |
3.10879999521063E-08 |
| Caucasian-vs-AfricanAmerican |
7.062800E-01 |
| Caucasian-vs-Asian |
4.830400E-01 |
| AfricanAmerican-vs-Asian |
8.971600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55431223447522E-15 |
| Normal-vs-Female |
1.63036251166204E-12 |
| Male-vs-Female |
1.886560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.58970622724064E-12 |
| Normal-vs-Age(41-60Yrs) |
1.50990331349021E-13 |
| Normal-vs-Age(61-80Yrs) |
1.70530256582424E-12 |
| Normal-vs-Age(81-100Yrs) |
1.008840E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.180200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.322390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.115200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.390800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.886600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.553000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.703770E-02 |
| Classical-VS-Follicular |
6.855600E-01 |
| Classical-VS-Other |
1.467950E-01 |
| Classical-VS-Normal |
1.62503344114384E-12 |
| Tall-VS-Follicular |
1.476280E-02 |
| Tall-VS-Other |
8.020000E-01 |
| Tall-VS-Normal |
5.07316411102465E-12 |
| Follicular-VS-Other |
2.323400E-01 |
| Follicular-VS-Normal |
9.76070000380247E-08 |
| Other-VS-Normal |
1.014410E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27484697745695E-13 |
| Normal-vs-N1 |
1.87569959564371E-11 |
| N0-vs-N1 |
2.530600E-01 |
|
|
